Standard BioTools
LAB
LAB
80 hedge funds and large institutions have $154M invested in Standard BioTools in 2017 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 19 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
4% less funds holding
Funds holding: 83 → 80 (-3)
21% less capital invested
Capital invested by funds: $196M → $154M (-$41.3M)
Holders
80
Holding in Top 10
1
Calls
$342K
Puts
$278K
Top Buyers
| 1 | +$10.4M | |
| 2 | +$4.03M | |
| 3 | +$3.8M | |
| 4 |
HVC
Healthcare Value Capital
Woodcliff Lake,
New Jersey
|
+$1.56M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$965K |
Top Sellers
| 1 | -$6.96M | |
| 2 | -$5.82M | |
| 3 | -$1.17M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$317K |
| 5 |
Morgan Stanley
New York
|
-$261K |